24 results on '"Eisen, Howard J."'
Search Results
2. Primum non Nocere: Induction in Kidney Transplantation After Heart Transplantation
3. Primum non Nocere: Induction in Kidney Transplantation After Heart Transplantation
4. Frailty and Its Impact on Posttransplant Outcomes
5. Impact of De Novo Everolimus-Based Immunosuppression on Incisional Complications in Heart Transplantation
6. Low Variability of Intraindividual Longitudinal Leukocyte Gene Expression Profiling Cardiac Allograft Rejection Scores
7. Early Growth Responsive Gene (Egr)-1 Expression Correlates with Cardiac Allograft Rejection
8. SAFETY, TOLERABILITY, AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL-BASED FORMULATION OF CYCLOSPORINE???RESULTS AT 24 MONTHS AFTER TRANSPLANTATION1
9. QUANTITATIVE ASSESSMENT OF CELL ADHESION MOLECULE GENE EXPRESSION IN ENDOMYOCARDIAL BIOPSY SPECIMENS FROM CARDIAC TRANSPLANT RECIPIENTS USING COMPETITIVE POLYMERASE CHAIN REACTION1
10. PHOTOPHERESIS FOR THE TREATMENT OF REFRACTORY CARDIAC REJECTION: AN OPEN LABEL RESCUE TRIAL.
11. EXPRESSION OF ALLOGRAFT INFLAMMATORY FACTOR-1 (AIF-1) IN VASCULAR SMOOTH MUSCLE CELLS OF CORONARY ARTERIES AND ENDOMYOCARDIAL BIOPSIES OF TRANSPLANTED HUMAN HEARTS.
12. EXPRESSION OF ALLOGRAFT INFLAMMATORY FACTOR-1 (AIF-1) IS A MARKER OF ACTIVATED HUMAN VASCULAR SMOOTH MUSCLE CELLS AND ARTERIAL INJURY.
13. RECOVERY OF LEFT VENTRICULAR FUNCTION IS MORE DELAYED IN CARDIAC TRANSPLANT RECIPIENTS WITH NON-CELLULAR (HUMORAL) REJECTION THAN IN RECIPIENTS WITH CELLULAR REJECTION.
14. SAFETY, TOLERABILITY AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL BASED FORMULATION OF CYCLOSPORINE - RESULTS AT SIX MONTHS AFTER TRANSPLANTATION1,2
15. THE TIME COURSE OF ICAM-1 AND VCAM-1 GENE EXPRESSION IN ENDOMYOCARDIAL BIOPSY SPECIMENS FROM CARDIAC TRANSPLANT RECIPIENTS: PREDICTIVE VALUE OF ENHANCED VCAM-1 GENE EXPRESSION FOR SUBSEQUENT SIGNIFICANT ALLOGRAFT REJECTION EPISODES
16. PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL WITH TRANSFORMING GROWTH FACTOR-β1 IN RATS
17. SAFETY, TOLERABILITY, AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL-BASED FORMULATION OF CYCLOSPORINE—RESULTS AT 24 MONTHS AFTER TRANSPLANTATION1
18. QUANTITATIVE ASSESSMENT OF CELL ADHESION MOLECULE GENE EXPRESSION IN ENDOMYOCARDIAL BIOPSY SPECIMENS FROM CARDIAC TRANSPLANT RECIPIENTS USING COMPETITIVE POLYMERASE CHAIN REACTION1.
19. NONINVASIVE ASSESSMENT OF TREATMENT OF CARDIAC ALLOGRAFT REJECTION WITH INDIUM-111-LABELED LYMPHOCYTES.
20. NONINVASIVE ASSESSMENT OF TREATMENT OF CARDIAC ALLOGRAFT REJECTION WITH INDIUM111-LABELED LYMPHOCYTES
21. CLINICAL IMPLEMENTATION OF A MOLECULAR DIAGNOSTIC ASSAY FOR THE NON-NVASIVE DETECTION OF CARDIAC ALLOGRAFT REJECTION.
22. RECOVERY OF LEFT VENTRICULAR FUNCTION IS MORE DELAYED IN CARDIAC TRANSPLANT RECIPIENTS WITH NONCELLULAR HUMORAL REJECTION THAN IN RECIPIENTS WITH CELLULAR REJECTION.
23. EXPRESSION OF ALLOGRAFT INFLAMMATORY FACTOR1 AIF1 IS A MARKER OF ACTIVATED HUMAN VASCULAR SMOOTH MUSCLE CELLS AND ARTERIAL INJURY.
24. EXPRESSION OF ALLOGRAFT INFLAMMATORY FACTOR1 AIF1 IN VASCULAR SMOOTH MUSCLE CELLS OF CORONARY ARTERIES AND ENDOMYOCARDIAL BIOPSIES OF TRANSPLANTED HUMAN HEARTS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.